These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32728595)

  • 1. Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical Trial.
    Anttila V; Saraste A; Knuuti J; Jaakkola P; Hedman M; Svedlund S; Lagerström-Fermér M; Kjaer M; Jeppsson A; Gan LM
    Mol Ther Methods Clin Dev; 2020 Sep; 18():464-472. PubMed ID: 32728595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting.
    Anttila V; Saraste A; Knuuti J; Hedman M; Jaakkola P; Laugwitz KL; Krane M; Jeppsson A; Sillanmäki S; Rosenmeier J; Zingmark P; Rudvik A; Garkaviy P; Watson C; Pangalos MN; Chien KR; Fritsche-Danielson R; Collén A; Gan LM
    Mol Ther; 2023 Mar; 31(3):866-874. PubMed ID: 36528793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate-Saline-Formulated mRNA Delivery into the Heart Muscle with an Electromechanical Mapping and Injection Catheter Does Not Lead to Therapeutic Effects in a Porcine Chronic Myocardial Ischemia Model.
    Järveläinen N; Halonen P; Nurro J; Hätinen OP; Korpela H; Mäkinen P; Gan LM; Fritsche-Danielson R; Ylä-Herttuala S
    Hum Gene Ther; 2021 Oct; 32(19-20):1295-1307. PubMed ID: 34494459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting.
    Depré C; Vanoverschelde JL; Gerber B; Borgers M; Melin JA; Dion R
    J Thorac Cardiovasc Surg; 1997 Feb; 113(2):371-8. PubMed ID: 9040632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF.
    Hughes GC; Biswas SS; Yin B; Coleman RE; DeGrado TR; Landolfo CK; Lowe JE; Annex BH; Landolfo KP
    Ann Thorac Surg; 2004 Mar; 77(3):812-8. PubMed ID: 14992878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous surgical revascularization and angiogenic gene therapy in diffuse coronary artery disease.
    Huwer H; Welter C; Ozbek C; Seifert M; Straub U; Greilach P; Kalweit G; Isringhaus H
    Eur J Cardiothorac Surg; 2001 Dec; 20(6):1128-34. PubMed ID: 11717016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study.
    Gyöngyösi M; Khorsand A; Zamini S; Sperker W; Strehblow C; Kastrup J; Jorgensen E; Hesse B; Tägil K; Bøtker HE; Ruzyllo W; Teresiñska A; Dudek D; Hubalewska A; Rück A; Nielsen SS; Graf S; Mundigler G; Novak J; Sochor H; Maurer G; Glogar D; Sylven C
    Circulation; 2005 Aug; 112(9 Suppl):I157-65. PubMed ID: 16159809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up and safety assessment of angiogenic gene therapy trial VIF-CAD: Transcatheter intramyocardial administration of a bicistronic plasmid expressing VEGF-A165/bFGF cDNA for the treatment of refractory coronary artery disease.
    Kukuła K; Urbanowicz A; Kłopotowski M; Dąbrowski M; Pręgowski J; Kądziela J; Chmielak Z; Witkowski A; Rużyłło W
    Am Heart J; 2019 Sep; 215():78-82. PubMed ID: 31288177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Revascularization on Absolute Myocardial Blood Flow as Assessed by Serial [
    Driessen RS; Danad I; Stuijfzand WJ; Schumacher SP; Knuuti J; Mäki M; Lammertsma AA; van Rossum AC; van Royen N; Raijmakers PG; Knaapen P
    Circ Cardiovasc Imaging; 2018 May; 11(5):e007417. PubMed ID: 29703779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractional flow reserve-guided coronary artery bypass grafting: can intraoperative physiologic imaging guide decision making?
    Ferguson TB; Chen C; Babb JD; Efird JT; Daggubati R; Cahill JM
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):824-835.e1. PubMed ID: 23915918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing patterns of patients undergoing emergency surgical revascularization for acute coronary occlusion. Importance of myocardial protection techniques.
    Beyersdorf F; Mitrev Z; Sarai K; Eckel L; Klepzig H; Maul FD; Ihnken K; Satter P
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):137-48. PubMed ID: 8320992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.
    Mandegar MH; Yousefnia MA; Roshanali F; Rayatzadeh H; Alaeddini F
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):930-6. PubMed ID: 18954632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial transfection of hypoxia inducible factor-1alpha via an adenoviral vector during coronary artery bypass grafting. - A multicenter phase I and safety study -.
    Kilian EG; Sadoni S; Vicol C; Kelly R; van Hulst K; Schwaiger M; Kupatt C; Boekstegers P; Pillai R; Channon K; Hetzer R; Reichart B
    Circ J; 2010 May; 74(5):916-24. PubMed ID: 20215699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose plasmid-mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial.
    Favaloro L; Diez M; Mendiz O; Janavel GV; Valdivieso L; Ratto R; Garelli G; Salmo F; Criscuolo M; Bercovich A; Crottogini A
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):899-906. PubMed ID: 22777825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD).
    Kukuła K; Chojnowska L; Dąbrowski M; Witkowski A; Chmielak Z; Skwarek M; Kądziela J; Teresińska A; Małecki M; Janik P; Lewandowski Z; Kłopotowski M; Wnuk J; Rużyłło W
    Am Heart J; 2011 Mar; 161(3):581-9. PubMed ID: 21392615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease--12-month follow-up: angiogenic gene therapy.
    Sarkar N; Rück A; Källner G; Y-Hassan S; Blomberg P; Islam KB; van der Linden J; Lindblom D; Nygren AT; Lind B; Brodin LA; Drvota V; Sylvén C
    J Intern Med; 2001 Nov; 250(5):373-81. PubMed ID: 11887971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of coronary bypass grafting onto the site of old myocardial infarction and the recovery of cardiac function.
    Ando H; Tanaka J; Hisahara M; Umesue M; Shirota T
    Cardiovasc Surg; 1998 Oct; 6(5):511-9. PubMed ID: 9794273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of coronary surgery in mildly symptomatic patients with left ventricular dysfunction, multivessel disease and stenotic single residual patent vessel].
    Dalle Mule J; Zingone B; Bilardo G; Sponga B; Pellegrini P; Branchini B; Burelli C; Zanuttini D; Martinelli F; Perelli R
    G Ital Cardiol; 1995 May; 25(5):561-74. PubMed ID: 7642061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision making and results of coronary artery bypass grafting for patients with poor left ventricular function.
    Uyar IS; Sahin V; Akpinar MB; Abacilar F; Yurtman V; Okur FF; Ates M; Tavli T
    Heart Surg Forum; 2013 Jun; 16(3):E118-24. PubMed ID: 23803233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial.
    Gasparovic H; Kopjar T; Rados M; Anticevic A; Rados M; Malojcic B; Ivancan V; Fabijanic T; Cikes M; Milicic D; Gasparovic V; Biocina B
    Trials; 2014 Oct; 15():414. PubMed ID: 25348157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.